Published in Ann Vasc Surg on February 01, 2010
Enhanced venous thrombus resolution in plasminogen activator inhibitor type-2 deficient mice. J Thromb Haemost (2014) 1.41
Impaired fibrinolytic system in ApoE gene-deleted mice with hyperlipidemia augments deep vein thrombosis. J Vasc Surg (2011) 0.97
The effect of matrix metalloproteinase 2 and matrix metalloproteinase 2/9 deletion in experimental post-thrombotic vein wall remodeling. J Vasc Surg (2013) 0.92
The role of urokinase plasminogen activator and plasmin activator inhibitor-1 on vein wall remodeling in experimental deep vein thrombosis. J Vasc Surg (2012) 0.92
Activated protein C accelerates venous thrombus resolution through heme oxygenase-1 induction. J Thromb Haemost (2014) 0.85
Matrix metalloproteinase-9 deletion is associated with decreased mid-term vein wall fibrosis in experimental stasis DVT. Thromb Res (2013) 0.80
Matrix Metalloproteinase 9 (MMP-9) Regulates Vein Wall Biomechanics in Murine Thrombus Resolution. PLoS One (2015) 0.75
Recanalization and flow regulate venous thrombus resolution and matrix metalloproteinase expression in vivo. J Vasc Surg Venous Lymphat Disord (2014) 0.75
Tissue destruction by neutrophils. N Engl J Med (1989) 13.81
The long-term clinical course of acute deep venous thrombosis. Ann Intern Med (1996) 6.87
Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res (2002) 6.37
Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res (2007) 5.60
Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest (2000) 4.90
Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest (2000) 4.79
Oral anticoagulant drugs. N Engl J Med (1991) 3.64
Mechanisms of venous thrombosis and resolution. Arterioscler Thromb Vasc Biol (2008) 1.93
Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins. J Clin Invest (2002) 1.91
Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med (2008) 1.91
Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. J Vasc Surg (1996) 1.66
Deep vein thrombosis resolution is modulated by monocyte CXCR2-mediated activity in a mouse model. Arterioscler Thromb Vasc Biol (2004) 1.49
Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes. Arterioscler Thromb Vasc Biol (1998) 1.48
New links between inflammation and thrombosis. Arterioscler Thromb Vasc Biol (2005) 1.35
Venous thrombosis-associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules. Arterioscler Thromb Vasc Biol (1995) 1.35
Failure of thrombus to resolve in urokinase-type plasminogen activator gene-knockout mice: rescue by normal bone marrow-derived cells. Circulation (2003) 1.35
Targeted deletion of CCR2 impairs deep vein thombosis resolution in a mouse model. J Immunol (2006) 1.30
Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model. J Vasc Surg (2005) 1.30
Mechanisms of endothelial cell heterogeneity in health and disease. Circ Res (2006) 1.21
Doxycycline inhibition of interleukin-1 in the corneal epithelium. Invest Ophthalmol Vis Sci (2000) 1.19
Novel roles for chemokines and fibroblasts in interstitial fibrosis. Kidney Int (1998) 1.10
Neutrophils modulate post-thrombotic vein wall remodeling but not thrombus neovascularization. Thromb Haemost (2006) 1.07
Differential regulation of matrix metalloproteinase-9 by monocytes adherent to collagen and platelets. Circ Res (2001) 1.07
Treatment with an oral small molecule inhibitor of P selectin (PSI-697) decreases vein wall injury in a rat stenosis model of venous thrombosis. J Vasc Surg (2006) 1.05
Adaptive cellular immunity in aortic aneurysms: cause, consequence, or context? J Clin Invest (2004) 1.05
Morphologic characteristics of varicose veins: possible role of metalloproteinases. J Vasc Surg (2003) 1.05
Fibrotic injury after experimental deep vein thrombosis is determined by the mechanism of thrombogenesis. Thromb Haemost (2007) 1.03
Determinants of chronic venous disease after acute deep venous thrombosis. J Vasc Surg (1998) 1.00
Low-dose low-molecular-weight heparin is anti-inflammatory during venous thrombosis. J Vasc Surg (1998) 0.96
Plasmin inhibition increases MMP-9 activity and decreases vein wall stiffness during venous thrombosis resolution. J Surg Res (2007) 0.95
Continuous periaortic infusion improves doxycycline efficacy in experimental aortic aneurysms. J Vasc Surg (2004) 0.93
Vein wall re-endothelialization after deep vein thrombosis is improved with low-molecular-weight heparin. J Vasc Surg (2008) 0.93
Adenoviral urokinase-type plasminogen activator (uPA) gene transfer enhances venous thrombus resolution. J Vasc Surg (2006) 0.90
Age-dependent impairment of reendothelialization after arterial injury: role of vascular endothelial growth factor. Circulation (2003) 0.88
P-selectin inhibition decreases post-thrombotic vein wall fibrosis in a rat model. Surgery (2003) 0.85
Proximate versus nonproximate risk factor associated primary deep venous thrombosis: clinical spectrum and outcomes. J Vasc Surg (2007) 0.84
Effect of heparin and related glycosaminoglycan on PDGF-induced lung fibroblast proliferation, chemotactic response and matrix metalloproteinases activity. Mediators Inflamm (2000) 0.84
Deep vein thrombosis resolution is impaired in diet-induced type 2 diabetic mice. J Vasc Surg (2008) 0.79
Multidetector computed tomography for acute pulmonary embolism. N Engl J Med (2006) 7.57
Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A (2010) 5.69
Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg (2004) 3.41
Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall. Blood (2004) 3.31
von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models. Blood (2010) 2.82
Neutrophil depletion inhibits experimental abdominal aortic aneurysm formation. Circulation (2005) 2.67
The care of patients with an abdominal aortic aneurysm: the Society for Vascular Surgery practice guidelines. J Vasc Surg (2009) 2.51
Propranolol induces regression of hemangioma cells through HIF-1α-mediated inhibition of VEGF-A. Ann Surg (2012) 2.35
SVS practice guidelines for the care of patients with an abdominal aortic aneurysm: executive summary. J Vasc Surg (2009) 2.16
The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg (2011) 2.15
Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II investigators. Am J Med (2006) 2.13
Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II Investigators. Radiology (2007) 2.09
Regional intensity of vascular care and lower extremity amputation rates. J Vasc Surg (2013) 1.95
Mechanisms of venous thrombosis and resolution. Arterioscler Thromb Vasc Biol (2008) 1.93
National trends in the use and outcomes of hepatic resection. J Am Coll Surg (2004) 1.92
Surgeon volume as an indicator of outcomes after carotid endarterectomy: an effect independent of specialty practice and hospital volume. J Am Coll Surg (2002) 1.91
Importance of refractory pain and hypertension in acute type B aortic dissection: insights from the International Registry of Acute Aortic Dissection (IRAD). Circulation (2010) 1.84
Osteomyelitis of the foot and toe in adults is a surgical disease: conservative management worsens lower extremity salvage. Ann Surg (2005) 1.76
Hepatic resection in the United States: indications, outcomes, and hospital procedural volumes from a nationally representative database. Arch Surg (2003) 1.74
Current concepts in the pathogenesis of abdominal aortic aneurysm. J Vasc Surg (2003) 1.74
Differential regulation of aortic growth in male and female rodents is associated with AAA development. J Surg Res (2008) 1.72
Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials. Eur Heart J (2008) 1.71
Matrix metalloproteinase induction of Rac1b, a key effector of lung cancer progression. Sci Transl Med (2012) 1.67
Role and results of surgery in acute type B aortic dissection: insights from the International Registry of Acute Aortic Dissection (IRAD). Circulation (2006) 1.66
Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study. J Vasc Surg (2002) 1.64
P-selectin and leukocyte microparticles are associated with venous thrombogenesis. J Vasc Surg (2003) 1.64
Surgical treatment of intact thoracoabdominal aortic aneurysms in the United States: hospital and surgeon volume-related outcomes. J Vasc Surg (2003) 1.63
Hospital teaching status and outcomes of complex surgical procedures in the United States. Arch Surg (2004) 1.59
A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg (2010) 1.59
The impact of provider volume on mortality after intracranial tumor resection. Neurosurgery (2003) 1.59
Identifying patients at high risk for venous thromboembolism requiring treatment after outpatient surgery. Ann Surg (2012) 1.55
Endovascular aortic aneurysm repair with carbon dioxide-guided angiography in patients with renal insufficiency. J Vasc Surg (2012) 1.53
Gender differences in experimental aortic aneurysm formation. Arterioscler Thromb Vasc Biol (2004) 1.51
Proteomics of microparticles after deep venous thrombosis. Thromb Res (2010) 1.50
Deep vein thrombosis resolution is modulated by monocyte CXCR2-mediated activity in a mouse model. Arterioscler Thromb Vasc Biol (2004) 1.49
The Michigan Surgical Quality Collaborative: a legacy of Shukri Khuri. Am J Surg (2009) 1.48
Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. J Vasc Surg (2007) 1.47
Pediatric renovascular hypertension: 132 primary and 30 secondary operations in 97 children. J Vasc Surg (2006) 1.47
Changes in the utilization of spinal fusion in the United States. Neurosurgery (2006) 1.46
Outcomes after cerebral aneurysm clip occlusion in the United States: the need for evidence-based hospital referral. J Neurosurg (2003) 1.46
Critical review of mouse models of venous thrombosis. Arterioscler Thromb Vasc Biol (2012) 1.46
L-selectin-mediated neutrophil recruitment in experimental rodent aneurysm formation. Circulation (2005) 1.44
Variation in postoperative complication rates after high-risk surgery in the United States. Surgery (2003) 1.42
Attending, house officer, and medical student perceptions about teaching in the third-year medical school general surgery clerkship. J Am Coll Surg (2004) 1.39
Impaired vasoreactivity despite an increase in plasma nitrite in patients with abdominal aortic aneurysms. J Vasc Surg (2002) 1.39
Tissue loss, early primary graft occlusion, female gender, and a prohibitive failure rate of secondary infrainguinal arterial reconstruction. J Vasc Surg (2002) 1.39
Variation in death rate after abdominal aortic aneurysmectomy in the United States: impact of hospital volume, gender, and age. Ann Surg (2002) 1.37
A true aneurysm of the profunda femoris artery: a case report and review of the English language literature. Ann Vasc Surg (2004) 1.34
Decreased venous thrombosis with an oral inhibitor of P selectin. J Vasc Surg (2005) 1.34
Genomewide significant linkage to recurrent, early-onset major depressive disorder on chromosome 15q. Am J Hum Genet (2004) 1.32
Targeted deletion of CCR2 impairs deep vein thombosis resolution in a mouse model. J Immunol (2006) 1.30
Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model. J Vasc Surg (2005) 1.30
Sonographic elasticity imaging of acute and chronic deep venous thrombosis in humans. J Ultrasound Med (2006) 1.29
A negative carotid plaque area test is superior to other noninvasive atherosclerosis studies for reducing the likelihood of having underlying significant coronary artery disease. Arterioscler Thromb Vasc Biol (2005) 1.29
Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer. Oncotarget (2014) 1.28
A population-based analysis of endovascular versus open thoracic aortic aneurysm repair. J Vasc Surg (2009) 1.27
Surgeon specialty and provider volumes are related to outcome of intact abdominal aortic aneurysm repair in the United States. J Vasc Surg (2003) 1.27
Hospital volume and surgical outcomes for elderly patients with colorectal cancer in the United States. J Surg Res (2003) 1.26
Who performs endocrine operations in the United States? Surgery (2003) 1.25
Measuring surgical quality: what's the role of provider volume? World J Surg (2005) 1.24
Genetic and pharmacologic disruption of interleukin-1β signaling inhibits experimental aortic aneurysm formation. Arterioscler Thromb Vasc Biol (2013) 1.23
The impact of adjusting for reliability on hospital quality rankings in vascular surgery. J Vasc Surg (2010) 1.23
Thrombogenesis with continuous blood flow in the inferior vena cava. A novel mouse model. Thromb Haemost (2010) 1.23
Female gender attenuates cytokine and chemokine expression and leukocyte recruitment in experimental rodent abdominal aortic aneurysms. Ann N Y Acad Sci (2006) 1.22
Racial disparities in the use of revascularization before leg amputation in Medicare patients. J Vasc Surg (2011) 1.22
Prophylactic P-selectin inhibition with PSI-421 promotes resolution of venous thrombosis without anticoagulation. Thromb Haemost (2008) 1.22
National trends in outcomes for esophageal resection. Ann Thorac Surg (2005) 1.21
Variation in the use of lower extremity vascular procedures for critical limb ischemia. Circ Cardiovasc Qual Outcomes (2011) 1.20
Interleukin-6: a potential target for post-thrombotic syndrome. Ann Vasc Surg (2010) 1.18
Payer status is related to differences in access and outcomes of abdominal aortic aneurysm repair in the United States. Surgery (2003) 1.17
A contemporary analysis of outcomes for operative repair of type A aortic dissection in the United States. Surgery (2007) 1.17